|
|
Article: Stentys expands Scientific Advisory Board SAB on heels of reporting successful clinical trial results for world's first self-expanding stent to treat AMI.(Clinical report)
- Article from:
- Heart Disease Weekly
- Article date:
- November 15, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Medical device pioneer Stentys announced that it has expanded its Scientific Advisory Board (SAB) by adding five distinguished interventional cardiologists (see also Stentys).
The expansion of the Stentys SAB follows closely the disclosure of results on 20 patients participating in the Company's 'APPOSITION I' clinical study-the world's first to treat patients with acute myocardial infarction (AMI) via a self-expanding stent. The study demonstrated that the coronary vessel expands a few days after treatment as vasospasm is relieved, and that the Stentys stent follows this expansion with perfect apposition.
The additions to the Stentys SAB include: Raoul ...